Sarepta Therapeutics
SRPT
$119.93
Share price
0.32%
Change (1 day)
24.78%
Change (1 year)
Categories
Sarepta Therapeutics is an American medical research company dedicated to the discovery and development of precisely effective gene therapeutics for the treatment of rare neuromuscular diseases.
Sarepta Therapeutics (SRPT) - Total assets
Total assets on the balance sheet as of June 2023 : $3.12 B
According to Sarepta Therapeutics 's latest financial reports the company's total assets are $3.12 B. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Sarepta Therapeutics - Total assets on balance sheet (from 2001 to 2023)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2022-12-31 | $3.12 B | -0.62% |
| 2021-12-31 | $3.14 B | 5.47% |
| 2020-12-31 | $2.98 B | 63.74% |
| 2019-12-31 | $1.82 B | 11.01% |
| 2018-12-31 | $1.64 B | 25.54% |
| 2017-12-31 | $1.30 B | 208.41% |
| 2016-12-31 | $0.42 B | 54.91% |
| 2015-12-31 | $0.27 B | -7.2% |
| 2014-12-31 | $0.29 B | 1.19% |
| 2013-12-31 | $0.29 B | 42.23% |
| 2012-12-31 | $0.20 B | 277.05% |
| 2011-12-31 | $54.36 M | 18.25% |
| 2010-12-31 | $45.97 M | -23.41% |
| 2009-12-31 | $60.02 M | 135.07% |
| 2008-12-31 | $25.53 M | -33.91% |
| 2007-12-31 | $38.63 M | -5.44% |
| 2006-12-31 | $40.86 M | -27.56% |
| 2005-12-31 | $56.4 M | 97.79% |
| 2004-12-31 | $28.51 M | -39.51% |
| 2003-12-31 | $47.14 M | 64.82% |
| 2002-12-31 | $28.6 M | -15.41% |
| 2001-12-31 | $33.81 M |
Total Assets for similar companies or competitors
| Company | Total assets | differencediff. | Country |
|---|---|---|---|
 Gilead Sciences GILD | $62.33 B | 1,894.22% | 🇺🇸 USA |
 PTC Therapeutics
PTCT | $1.33 B | -57.19% | 🇺🇸 USA |
 Novavax NVAX | $1.68 B | -46.09% | 🇺🇸 USA |
 Alnylam Pharmaceuticals
ALNY | $3.40 B | 8.85% | 🇺🇸 USA |
 Insmed INSM | $1.43 B | -53.96% | 🇺🇸 USA |
 BioCryst Pharmaceuticals
BCRX | $0.52 B | -83.05% | 🇺🇸 USA |
 Avidity Biosciences RNA | $0.61 B | -80.46% | 🇺🇸 USA |